Exelixis

YTD

ALL

Trade Exelixis 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About EXEL

Exelixis, Inc. operates as an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic.

CEO

Michael M. Morrissey

CEOMichael M. Morrissey

Employees

1,147

Employees1,147

Headquarters

Alameda, California

HeadquartersAlameda, California

Founded

1994

Founded1994

Employees

1,147

Employees1,147

EXEL Key Statistics

Market cap

11.09B

Market cap11.09B

Price-Earnings ratio

17.80

Price-Earnings ratio17.80

Dividend yield

—

Dividend yield—

Average volume

2.40M

Average volume2.40M

High today

$42.50

High today$42.50

Low today

$40.80

Low today$40.80

Open price

$42.12

Open price$42.12

Volume

3.44M

Volume3.44M

52 Week high

$49.62

52 Week high$49.62

52 Week low

$32.38

52 Week low$32.38

Stock Snapshot

The current Exelixis(EXEL) stock price is $41.74, with a market capitalization of 11.09B. The stock trades at a price-to-earnings (P/E) ratio of 17.80.

During the trading session on 2026-01-30, Exelixis(EXEL) shares reached a daily high of $42.50 and a low of $40.80. At a current price of $41.74, the stock is +2.3% higher than the low and still -1.8% under the high.

Trading activity shows a volume of 3.44M, compared to an average daily volume of 2.4M.

Over the past 52 weeks, Exelixis(EXEL) stock has traded between a high of $49.62 and a low of $32.38.

EXEL News

Nasdaq 12h

EXEL Makes Notable Cross Below Critical Moving Average

In trading on Thursday, shares of Exelixis Inc (Symbol: EXEL) crossed below their 200 day moving average of $38.49, changing hands as low as $38.27 per share. E...

TipRanks 4d

Exelixis price target raised to $52 from $49 at H.C. Wainwright

H.C. Wainwright raised the firm’s price target on Exelixis (EXEL) to $52 from $49 and keeps a Buy rating on the shares. The company issued “encouraging” 2026 fi...

Simply Wall St 6d

Assessing Exelixis Valuation After New Guidance Collaboration And Buyback Updates

Exelixis (EXEL) is back in focus after a wave of updates, including fresh 2025 preliminaries, 2026 revenue guidance between US$2.525b and US$2.625b, new collabo...

Analyst ratings

50%

of 22 ratings

Buy

45.5%

Hold

50%

Sell

4.5%

People also own

Based on the portfolios of people who own EXEL. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.